Founding Cohort 2026, 11 spots remaining · 50% off Founders Rate For Life →
Authoritize.ai
Back to Atlas
CRITICALGLP-1 / Weight Loss

New Life Pharma LLC

FDA issued a warning letter to New Life Pharma LLC (Northvale, NJ) after a February 2026 inspection found the company was manufacturing and distributing unapproved semaglutide and tirzepatide sterile multi-dose vials — GLP-1 drugs shipped primarily to weight loss clinics and med spas — without FDA approval, proper registration, or adequate sterility controls. The products were deemed unapproved new drugs, misbranded, and adulterated due to pervasive CGMP failures including no aseptic process validation, no environmental monitoring, and no sterility testing. The company also denied FDA investigators access to portions of its manufacturing suite, further adulterating the drugs under FD&C Act section 501(j). A voluntary recall of all distributed batches was issued on February 25, 2026, and FDA demanded the firm confirm it will permanently cease drug manufacturing.

Rx-only

Sterile Multi-Dose Vial; Refrigerate after reconstitution

Semaglutide Sterile Multi-Dose Vial

Tirzepatide Sterile Multi-Dose Vial

Your 'Semaglutide Sterile Multi-Dose Vial' and 'Tirzepatide Sterile Multi-Dose Vial' products are unapproved new drugs under section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a).

On February 25, 2026, you issued a voluntary recall of semaglutide and tirzepatide sterile multi-dose vials due to lack of assurance of sterility.

Considering all the drugs you manufactured are not approved by the agency and your systems for manufacturing sterile drugs are wholly lacking, you should not restart drug manufacturing at this facility. In response to this letter confirm that you will not manufacture drugs in the future.

After you receive this letter, respond to this office in writing within 15 working days. Specify what you have done to address any deviations and to prevent their recurrence.

Does your site contain similar claims?

The free site audit scans your site against every entry in this Atlas. Most glp-1 / weight loss sites match 3-6 patterns.

Run my free site audit